Skip to main content
. 2022 Apr 20;9:889688. doi: 10.3389/fmolb.2022.889688

TABLE 1.

Clinical characteristics of the COAD patients.

Characteristic Levels Overall
N 478
Tumor extent (T) stage, n (%) T1 11 (2.3%)
T2 83 (17.4%)
T3 323 (67.7%)
T4 60 (12.6%)
Lymph node invasion (N) stage, n (%) N0 284 (59.4%)
N1 108 (22.6%)
N2 86 (18%)
Detectable metastasis (M) stage, n (%) M0 349 (84.1%)
M1 66 (15.9%)
Pathologic stage, n (%) Stage I 81 (17.3%)
Stage II 187 (40%)
Stage III 133 (28.5%)
Stage IV 66 (14.1%)
Age, n (%) <=65 194 (40.6%)
>65 284 (59.4%)
Lymphatic invasion, n (%) NO 266 (61.3%)
YES 168 (38.7%)
Overall survival (OS) event, n (%) Alive 375 (78.5%)
Dead 103 (21.5%)
Gender, n (%) Female 226 (47.3%)
Male 252 (52.7%)
Age, median (IQR) 69 (58, 77)

Note: A small amount of samples may be lost during the statistics of different clinical variables in the TCGA database. T1, the carcinoma invaded the submucosa but not involve the lamina propria; T2, the carcinoma invaded the lamina propria; T3, the carcinoma penetrated the lamina propria; T4, the carcinoma invaded the visceral peritoneum or adhered to adjacent organs; N0, no regional lymph node metastasis; N1, limited to 1–3 regional lymph node metastases, or no regional lymph node metastasis, but any number of tumor nodules; N2, four or more regional lymph nodes metastases; M0, imaging showed no distant metastasis; M1, metastases to one or more distant sites, organs, or peritoneum; Stage I, the carcinoma confined within the intestinal wall; Stage II, the carcinoma penetrated the intestinal wall and invaded the mucosa or serosa without lymph node metastasis; Stage III, local lymph node metastasis; and Stage IV, invasion of adjacent organs or distant metastasis.